3.400 Erwachsene mit Adipositas ohne Diabetes, 68 Wochen) fhrte die Kombination Cagrilintid + Semaglutid (CagriSema) zu einer durchschnittlichen Gewichtsreduktion von 20,4 % , gegenber 11,5 % fr Cagrilintid allein, 14,9 % fr Semaglutid allein und 3 % fr Placebo
In placebo-controlled trials of semaglutide injection for weight management, headache (14%), fatigue (11%), and dizziness (8%) were reported in treated patients
Optimal dosing protocols are based on extrapolation rather than controlled human research
Format options Pre-blended vials (most common: 12.5 mg reta + 2.5 mg cag) or two separate vials
The enclosed networks of tubes were photographed 12 hours later using Canon PowerShot A640 camera on Zeiss inverted microscope with 100 magnification